Organogenesis Holdings Inc(ORGO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ORGO Organogenesis Holdings Inc

盘后交易 04-30 18:14:31 EDT

2.35

+0.05

+2.17%

盘后2.39

+0.04+1.70%

16:46 EDT

最高2.37	最低2.29	成交量97.96万
今开2.30	昨收2.30	日振幅3.48%
总市值3.02亿	流通市值1.36亿	总股本1.29亿
成交额228.75万	换手率1.69%	流通股本5,795万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ORGO","market":"US","secType":"STK","nameCN":"Organogenesis Holdings Inc","latestPrice":2.35,"timestamp":1777579200000,"preClose":2.3,"halted":0,"volume":979615,"hourTrading":{"tag":"盘后","latestPrice":2.39,"preClose":2.35,"latestTime":"16:46 EDT","volume":19,"amount":44.7151985,"timestamp":1777581998290,"change":0.04,"changeRate":0.017021,"amplitude":0.03183},"delay":0,"changeRate":0.021739130434782726,"floatShares":57945200,"shares":128640671,"eps":0.15,"marketStatus":"盘后交易","change":0.05,"latestTime":"04-30 18:14:31 EDT","open":2.3,"high":2.37,"low":2.29,"amount":2287531.6076795,"amplitude":0.034783,"askPrice":2.5,"askSize":500,"bidPrice":2.21,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.15,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777593600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.3,"preHourTrading":{"tag":"盘前","latestPrice":2.3176,"preClose":2.3,"latestTime":"09:09 EDT","volume":2775,"amount":6346.0226250000005,"timestamp":1777554597867,"change":0.0176,"changeRate":0.007652,"amplitude":0.02587},"postHourTrading":{"tag":"盘后","latestPrice":2.39,"preClose":2.35,"latestTime":"16:46 EDT","volume":19,"amount":44.7151985,"timestamp":1777581998290,"change":0.04,"changeRate":0.017021,"amplitude":0.03183},"volumeRatio":0.911647,"impliedVol":0.6896,"impliedVolPercentile":0.239},"requestUrl":"/m/hq/s/ORGO","defaultTab":"news","newsList":[{"id":"1193732673","title":"Organogenesis宣布与FDA会议圆满成功 计划提交Renu®治疗膝骨关节炎疼痛的生物制剂许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1193732673","media":"美股速递","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193732673?lang=zh_cn&edition=full","pubTime":"2026-04-07 05:31","pubTimestamp":1775511075,"startTime":"0","endTime":"0","summary":"再生医学巨头Organogenesis Holdings Inc（ORGO）近日宣布，已顺利完成与美国食品药品监督管理局（FDA）的关键性会议。双方就Renu®再生细胞技术用于治疗膝骨关节炎疼痛的临床开发路径达成共识。\n公司明确表示，将基于会议指导加速推进监管申报流程，计划正式提交生物制剂许可申请（BLA）。这款创新疗法旨在通过细胞再生机制靶向修复膝关节软骨组织，有望为全球数亿骨关节炎患者提供非手术干预新选择。\n此次里程碑事件标志着Renu®产品商业化进程取得重大突破。业界分析指出，若获批上市，该产品或将重塑骨科疼痛治疗领域市场格局。受此利好消息影响，公司股价在盘后交易中呈现上扬态势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592790725","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592790725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592790725?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:33","pubTimestamp":1766068385,"startTime":"0","endTime":"0","summary":"北京时间2025年12月18日22时33分，Organogenesis Holdings Inc.股票出现波动，股价急速上涨5.12%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为1.08%。其相关个股中，Akanda Corp.、Canopy Growth Corporation、Tilray Brands, Inc.涨幅较大，Akanda Corp.、Cbdmd, Inc.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为421.56%、70.65%、4.28%，振幅较大的相关个股有Biofrontera Inc.、Akanda Corp.、Cbdmd, Inc.，振幅分别为13.89%、10.35%、8.15%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场产品解决方案的开发、制造和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822330697a0760d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025121822330697a0760d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101439563","title":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","url":"https://stock-news.laohu8.com/highlight/detail?id=1101439563","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101439563?lang=zh_cn&edition=full","pubTime":"2025-12-16 05:25","pubTimestamp":1765833911,"startTime":"0","endTime":"0","summary":"Organogenesis宣布成功召开FDA会议并计划提交Renu®的生物制剂申请以治疗膝关节骨关节炎疼痛","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517453907","title":"Organogenesis Holdings Inc.2024财年实现净利润861000.00美元，同比减少82.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517453907","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517453907?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363255,"startTime":"0","endTime":"0","summary":"3月8日，Organogenesis Holdings Inc.公布财报，公告显示公司2024财年净利润为861000.00美元，同比减少82.61%；其中营业收入为4.82亿美元，同比增加11.32%，每股基本收益为0.01美元。机构评级：截至2025年3月8日，当前有4家机构对Organogenesis Holdings Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为5.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000245abed66e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000245abed66e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128515965","title":"异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128515965","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128515965?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:33","pubTimestamp":1741185225,"startTime":"0","endTime":"0","summary":"Organogenesis Holdings Inc(股票代码:ORGO)今日盘中股价大涨5.16%,引起了市场的广泛关注。\n\n从消息面上看,大摩证券分析师刚刚调高了对ORGO的目标股价,由之前的4.00美元上调至6.00美元。此外,大摩维持了对ORGO的\"持股观望\"评级。这表明分析师对ORGO的长期前景持乐观态度,投资者受此利好消息影响,推高了ORGO股价。\n\n总的来说,分析师上调目标股价,提振了投资者对ORGO未来发展前景的信心,导致了今日ORGO股价的大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 大摩上调Organogenesis Holdings目标价致其股价大涨5.16%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517316948","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.16%报5.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316948","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517316948?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185107,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Organogenesis Holdings Inc.股票出现异动，股价大幅上涨5.16%。截至发稿，该股报5.30美元/股，成交量5.7391万股，换手率0.05%，振幅1.70%。Organogenesis Holdings Inc.股票所在的制药行业中，整体跌幅为0.20%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223147963adc5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223147963adc5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517917991","title":"大摩：维持Organogenesis Holdings(ORGO.US)评级，由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517917991","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517917991?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:14","pubTimestamp":1741184061,"startTime":"0","endTime":"0","summary":"大摩：维持Organogenesis Holdings(ORGO.US)评级，由持股观望调整至持股观望评级, 目标价由4.00美元调整至6.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05221448547688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516791670","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516791670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516791670?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:31","pubTimestamp":1741098697,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时31分，Organogenesis Holdings Inc.股票出现波动，股价快速跳水5.18%。截至发稿，该股报5.13美元/股，成交量4.5083万股，换手率0.04%，振幅0.83%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.04%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223137abe7ef52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223137abe7ef52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516863403","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516863403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516863403?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:41","pubTimestamp":1741012892,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时41分，Organogenesis Holdings Inc.股票出现波动，股价急速上涨5.11%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.35%。其相关个股中，Sunshine Biopharma Inc C/Wts 、Scilex Holding Company、Intercure Ltd.涨幅较大，苏轩堂、Petros Pharmaceuticals, Inc.、大自然药业较为活跃，换手率分别为6.33%、3.47%、3.04%，振幅较大的相关个股有Organogenesis Holdings Inc.、Redhill Biopharma Ltd、Scilex Holding Company，振幅分别为9.02%、7.50%、6.36%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224133abe6368a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224133abe6368a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514889378","title":"Organogenesis Holdings Inc.盘中异动 急速拉升30.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514889378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514889378?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753071,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Organogenesis Holdings Inc.股票出现波动，股价快速拉升30.94%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.01%。其相关个股中，Organogenesis Holdings Inc.、百利高、Ani Pharmaceuticals, Inc.涨幅较大，Petros Pharmaceuticals, Inc.、大自然药业、Quantum Biopharma Ltd.较为活跃，换手率分别为1.97%、1.39%、0.63%，振幅较大的相关个股有Kamada Ltd.、Esperion Therapeutics, Inc.、Organogenesis Holdings Inc.，振幅分别为3.62%、1.66%、1.57%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223111abe0ea07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223111abe0ea07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196357298","title":"Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期，销售额 $1.2666 亿超出 $1.0960 亿的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1196357298","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196357298?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:31","pubTimestamp":1740691919,"startTime":"0","endTime":"0","summary":"公司报告季度销售额为 $1.2666 亿，超出分析师一致预期的 $1.0960 亿，增长了 15.56%。以上内容来自Benzinga Earnings专栏，原文如下：Organogenesis Hldgs  reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $ by 800 percent. This is a 600 percent increase over earnings of $0.01 per share from the same period last year.  The company reported quarterly sales of $126.66 million which beat the analyst consensus estimate of $109.60 million by 15.56 percent.  This is a 27.10 percent increase over sales of $99.6","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Organogenesis Hldgs 第四季度调整后每股收益 $0.07 超出 $(0.01) 的预期，销售额 $1.2666 亿超出 $1.0960 亿的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514833053","title":"Organogenesis Holdings Inc.盘中异动 急速跳水5.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514833053?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:01","pubTimestamp":1740690119,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日05时01分，Organogenesis Holdings Inc.股票出现异动，股价快速下挫5.54%。截至发稿，该股报3.07美元/股，成交量38.6882万股，换手率0.31%，振幅6.46%。Organogenesis Holdings Inc.股票所在的制药行业中，整体跌幅为0.47%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228050200989556c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228050200989556c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508317144","title":"Organogenesis Holdings Inc.盘中异动 早盘股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508317144","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508317144?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:53","pubTimestamp":1738594417,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时53分，Organogenesis Holdings Inc.股票出现异动，股价快速下跌5.16%。截至发稿，该股报3.49美元/股，成交量4.2559万股，换手率0.03%，振幅2.45%。Organogenesis Holdings Inc.股票所在的制药行业中，整体跌幅为0.09%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225337987972e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203225337987972e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507354467","title":"Organogenesis Holdings Inc.盘中异动 下午盘急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507354467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507354467?lang=zh_cn&edition=full","pubTime":"2025-01-29 02:10","pubTimestamp":1738087839,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时10分，Organogenesis Holdings Inc.股票出现异动，股价大幅下挫5.08%。Organogenesis Holdings Inc.股票所在的制药行业中，整体跌幅为0.28%。其相关个股中，Cbdmd, Inc.、Eton Pharmaceuticals, Inc.、Aquestive Therapeutics, Inc.涨幅较大，Cbdmd, Inc.、Painreform Ltd.、Inmed Pharmaceuticals Inc.较为活跃，换手率分别为252.00%、24.20%、6.41%，振幅较大的相关个股有Cbdmd, Inc.、Painreform Ltd.、Shuttle Pharmaceuticals Holdings, Inc.，振幅分别为48.61%、13.35%、12.94%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021039abbb9159&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129021039abbb9159&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506305285","title":"Organogenesis Holdings Inc.盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506305285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506305285?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:38","pubTimestamp":1737988723,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时38分，Organogenesis Holdings Inc.股票出现波动，股价大幅上涨5.06%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.87%。其相关个股中，Alpha Teknova, Inc.、Sunshine Biopharma Inc C/Wts 、Scilex Holding Company涨幅较大，Painreform Ltd.、大自然药业、苏轩堂较为活跃，换手率分别为25.63%、5.79%、5.61%，振幅较大的相关个股有Alpha Teknova, Inc.、Petros Pharmaceuticals, Inc.、Scilex Holding Company，振幅分别为9.02%、7.90%、6.79%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223844a2316c90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223844a2316c90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505202496","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.39%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505202496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505202496?lang=zh_cn&edition=full","pubTime":"2025-01-22 02:06","pubTimestamp":1737482813,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日02时06分，Organogenesis Holdings Inc.股票出现异动，股价急速上涨5.39%。截至发稿，该股报3.52美元/股，成交量8.0796万股，换手率0.06%，振幅4.49%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为1.44%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。其部分产品包括 PuraPly Antimicrobial、Affinity、NuShield、Apligraf、Dermagraft 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020653986e58f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122020653986e58f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ORGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502983598","title":"Organogenesis Holdings Inc.盘中异动 早盘急速跳水5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502983598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502983598?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:05","pubTimestamp":1736521538,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时05分，Organogenesis Holdings Inc.股票出现波动，股价大幅下挫5.11%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.33%。其相关个股中，Intra-Cellular Therapies Inc.、Pacira Biosciences, Inc.、Intercure Ltd.涨幅较大，大自然药业、Cbdmd, Inc.、Biofrontera Inc.较为活跃，换手率分别为15.36%、6.03%、4.01%，振幅较大的相关个股有Intra-Cellular Therapies Inc.、Kamada Ltd.、Citius Oncology, Inc.，振幅分别为14.38%、12.24%、10.49%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230538a21d168d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110230538a21d168d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2500086429","title":"Organogenesis Holdings Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500086429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500086429?lang=zh_cn&edition=full","pubTime":"2025-01-03 02:33","pubTimestamp":1735842818,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日02时33分，Organogenesis Holdings Inc.股票出现异动，股价快速下跌5.00%。截至发稿，该股报3.04美元/股，成交量21.9627万股，换手率0.17%，振幅7.34%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为0.19%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。其部分产品包括 PuraPly Antimicrobial、Affinity、NuShield、Apligraf、Dermagraft 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103023338a2133665&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103023338a2133665&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2494339203","title":"Organogenesis Holdings Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494339203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494339203?lang=zh_cn&edition=full","pubTime":"2024-12-28 01:19","pubTimestamp":1735319987,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日01时19分，Organogenesis Holdings Inc.股票出现波动，股价大幅下挫5.03%。截至发稿，该股报3.12美元/股，成交量16.4313万股，换手率0.13%，振幅7.62%。Organogenesis Holdings Inc.股票所在的制药行业中，整体跌幅为0.92%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011947a20c2015&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228011947a20c2015&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2493793870","title":"Organogenesis Holdings Inc.盘中异动 股价大涨5.08%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493793870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493793870?lang=zh_cn&edition=full","pubTime":"2024-12-24 01:11","pubTimestamp":1734973913,"startTime":"0","endTime":"0","summary":"北京时间2024年12月24日01时11分，Organogenesis Holdings Inc.股票出现异动，股价快速上涨5.08%。截至发稿，该股报3.21美元/股，成交量12.9512万股，换手率0.10%，振幅5.74%。Organogenesis Holdings Inc.股票所在的制药行业中，整体涨幅为1.69%。Organogenesis Holdings Inc.公司简介：Organogenesis Holdings Inc 是一家再生医学公司，专注于为高级伤口护理、外科和运动医学市场开发、制造和商业化产品解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011153984d3dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224011153984d3dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ORGO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.organogenesis.com","stockEarnings":[{"period":"1week","weight":-0.0456},{"period":"1month","weight":0.0044},{"period":"3month","weight":-0.4264},{"period":"6month","weight":-0.4588},{"period":"1year","weight":-0.5287},{"period":"ytd","weight":-0.556}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.126},{"period":"3month","weight":0.0253},{"period":"6month","weight":0.0433},{"period":"1year","weight":0.2837},{"period":"ytd","weight":0.0435}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Organogenesis Holdings Inc.是特拉华州的一家公司。该公司是一家领先的再生医学公司，在先进的伤口护理和外科生物制剂（包括骨科和脊柱）中提供生物活性和非细胞生物材料产品组合。Organogenesis全面的产品组合旨在治疗各种有修复和再生需求的患者。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":0.030316},{"month":2,"riseRate":0.4,"avgChangeRate":0.031483},{"month":3,"riseRate":0.4,"avgChangeRate":-0.079947},{"month":4,"riseRate":0.3,"avgChangeRate":0.004759},{"month":5,"riseRate":0.444444,"avgChangeRate":0.027529},{"month":6,"riseRate":0.444444,"avgChangeRate":0.014138},{"month":7,"riseRate":0.666667,"avgChangeRate":0.038466},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.058414},{"month":9,"riseRate":0.444444,"avgChangeRate":0.019558},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.057674},{"month":11,"riseRate":0.5,"avgChangeRate":0.080332},{"month":12,"riseRate":0.25,"avgChangeRate":0.091349}],"exchange":"NASDAQ","name":"Organogenesis Holdings Inc","nameEN":"Organogenesis Holdings Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Organogenesis Holdings Inc(ORGO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Organogenesis Holdings Inc(ORGO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Organogenesis Holdings Inc,ORGO,Organogenesis Holdings Inc股票,Organogenesis Holdings Inc股票老虎,Organogenesis Holdings Inc股票老虎国际,Organogenesis Holdings Inc行情,Organogenesis Holdings Inc股票行情,Organogenesis Holdings Inc股价,Organogenesis Holdings Inc股市,Organogenesis Holdings Inc股票价格,Organogenesis Holdings Inc股票交易,Organogenesis Holdings Inc股票购买,Organogenesis Holdings Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Organogenesis Holdings Inc(ORGO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Organogenesis Holdings Inc(ORGO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}